G01N 2800/7095
Inflammation
G01N2800/7095 (Inflammation) appears on 213 US grants and 509 published applications in this corpus.
Search patents in G01N- Granted patents
- 213
- Published applications
- 509
- Assignees
- 313
- Inventors
- 1,010
- Latest grant
- 25 Aug 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2002 | 0 | 1 |
| 2003 | 0 | 0 |
| 2004 | 0 | 3 |
| 2005 | 1 | 0 |
| 2006 | 0 | 1 |
| 2007 | 2 | 3 |
| 2008 | 0 | 1 |
| 2009 | 0 | 3 |
| 2010 | 1 | 10 |
| 2011 | 2 | 2 |
| 2012 | 0 | 15 |
| 2013 | 1 | 12 |
| 2014 | 4 | 25 |
| 2015 | 13 | 38 |
| 2016 | 12 | 45 |
| 2017 | 20 | 29 |
| 2018 | 30 | 35 |
| 2019 | 13 | 44 |
| 2020 | 18 | 38 |
| 2021 | 20 | 43 |
| 2022 | 13 | 31 |
| 2023 | 12 | 43 |
| 2024 | 19 | 35 |
| 2025 | 20 | 36 |
| 2026 | 12 | 16 |
By publication year. 2026 runs to 8 Oct.
Recent patents
- Microfluidic-based device for in vivo wound infection model and uses thereof25 Aug 2026US 12,716,889 B2City Unversity of Hong Kong
- Antibody specifically binding to WRS protein, and use thereof23 Jun 2026US 12,663,424 B2Jw Bioscience
- Device and method to determine the mean/average control of asthma/COPD over time and compliance to treatment9 Jun 2026US 12,648,713 B2
- Non-invasive assay for detecting and monitoring systemic inflammation19 May 2026US 12,631,654 B2Ichilov Tech Ltd.
- Method of identifying pro-inflammatory dendritic cells5 May 2026US 12,618,837 B2Agency for Science, Technology and Research
- Non-invasive assay for detecting and monitoring systemic inflammation17 Sep 2026US 2026/0276654 A1Ichilov Tech Ltd.
- Analysis of bodily emissions10 Sep 2026US 2026/0266806 A1Outsense Diagnostics Ltd.
- Pvax14 nucleic acid formulated with nano-vehicle in combination with all-trans retinoic acid (atra) for activating immune pathways13 Aug 2026US 2026/0232777 A1Assistance Publique-Hopitaux de Paris
- Cd59 for inhibiting inflammasome activation13 Aug 2026US 2026/0232845 A1Trustees of Tufts College
- Marker and method for detecting inflammation-related diseases25 Jun 2026US 2026/0176332 A1Beijing Mdtk Biotechnology Co., Ltd.
Most cited
By later US patents
- Minimally-invasive measurement of esophageal inflammation34US 8,637,239 B2The Board of Trustees of the University of Illinois · 2014
- Methods for treating vascular leak syndrome29US 9,096,555 B2Aerpio Therapeutics Inc. · 2015
- Methods of treating inflammatory and autoimmune diseases with natalizumab29US 9,493,567 B2Biogen, Inc. · 2016
- Methods of treating or diagnosing conditions associated with elevated IL-6 using anti-IL-6 antibodies or fragments26US 9,452,227 B2Alderbio Holdings LLC · 2016
- Antibodies that bind to TL1A and methods of treating inflammatory or autoimmune disease comprising administering such antibodies25US 9,068,003 B2The United States of America, as represented by the Secretary, Dept. of Health and Human Services · 2015